JMP Securities Starts Inhibrx Biosciences. (INBX) at Market Perform

July 23, 2024 3:02 AM EDT Send to a Friend
JMP Securities analyst Reni Benjamin initiates coverage on Inhibrx Inc. (NASDAQ: INBX) with a Market Perform rating.The analyst comments: "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login